X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2926) 2926
Publication (150) 150
Book Chapter (24) 24
Book Review (18) 18
Dissertation (13) 13
Conference Proceeding (5) 5
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
interferon-α (1768) 1768
humans (1512) 1512
interferon-alpha (1128) 1128
male (863) 863
female (846) 846
middle aged (679) 679
adult (640) 640
interferon-alpha - therapeutic use (584) 584
index medicus (499) 499
interferon α (421) 421
oncology (410) 410
animals (386) 386
aged (381) 381
therapy (335) 335
interferon‐α (316) 316
recombinant proteins (311) 311
interferon alpha (308) 308
interferon-alpha - administration & dosage (306) 306
interferon (276) 276
immunology (269) 269
interferon-alpha - pharmacology (259) 259
treatment outcome (255) 255
gastroenterology & hepatology (249) 249
antiviral agents - therapeutic use (241) 241
interferon-alpha - adverse effects (234) 234
ribavirin (224) 224
mice (219) 219
expression (202) 202
hepatitis c virus (199) 199
hepatitis c, chronic - drug therapy (199) 199
hematology (197) 197
hepatitis c (196) 196
chronic hepatitis c (188) 188
interleukin-2 (154) 154
immunotherapy (149) 149
biological response modifiers (148) 148
infection (146) 146
cancer (142) 142
drug therapy, combination (137) 137
adolescent (136) 136
medicine, research & experimental (135) 135
cytokines (128) 128
biochemistry & molecular biology (126) 126
antineoplastic combined chemotherapy protocols - therapeutic use (125) 125
renal cell carcinoma (124) 124
cells (123) 123
pharmacology & pharmacy (120) 120
chronic myelogenous leukemia (119) 119
antineoplastic agents - therapeutic use (118) 118
time factors (116) 116
virology (115) 115
apoptosis (114) 114
medicine & public health (112) 112
activation (106) 106
interferon-alpha - metabolism (106) 106
virus-infection (104) 104
dendritic cells (103) 103
ifn-alpha (102) 102
melanoma (101) 101
cells, cultured (100) 100
chemotherapy (100) 100
follow-up studies (99) 99
hepacivirus - genetics (99) 99
antiviral agents - adverse effects (98) 98
health aspects (95) 95
induction (93) 93
interferon-γ (92) 92
prognosis (91) 91
interferon-alpha - genetics (90) 90
genotype (88) 88
interferon-alpha - immunology (86) 86
ribavirin - therapeutic use (85) 85
chronic hepatitis b (84) 84
dose-response relationship, drug (82) 82
disease (81) 81
cell line (80) 80
cell line, tumor (79) 79
infectious diseases (79) 79
survival (78) 78
cell biology (77) 77
combination (77) 77
interferon alpha-2 (76) 76
child (75) 75
hepatocellular carcinoma (75) 75
tumor cells, cultured (75) 75
care and treatment (73) 73
5-fluorouracil (72) 72
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (72) 72
aged, 80 and over (71) 71
combined modality therapy (71) 71
combination therapy (70) 70
virus (70) 70
article (69) 69
prospective studies (69) 69
antiviral agents - administration & dosage (68) 68
antiviral agents - pharmacology (68) 68
hepatitis (68) 68
hepatitis c - drug therapy (68) 68
neurosciences (68) 68
rats (67) 67
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2679) 2679
German (78) 78
Japanese (63) 63
French (29) 29
Chinese (24) 24
Korean (22) 22
Polish (18) 18
Russian (13) 13
Spanish (11) 11
Italian (9) 9
Turkish (5) 5
Czech (4) 4
Slovenian (3) 3
Hungarian (2) 2
Portuguese (2) 2
Slovak (2) 2
Bosnian (1) 1
Dutch (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in Molecular Medicine, ISSN 1471-4914, 10/2019
Journal Article
Annals of Oncology, ISSN 0923-7534, 6/2008, Volume 19, Issue 6, pp. 1195 - 1201
Background: More than half of patients with melanoma that has spread to regional lymph nodes develop recurrent disease within the first 3 years after surgery.... 
Immunotherapy, interferon α | Dacarbazine | Adjuvant treatment | Melanoma
Journal Article
Cytokine, ISSN 1043-4666, 01/2020, Volume 125, p. 154822
Plasmacytoid dendritic cells (pDCs) are major producers of type I interferons in response to activation of endosomal toll-like receptors (TLRs), e.g. TLR9.... 
CAMKII | TLR9 | Interferon-α | Calcium | Calcineurin | pDC
Journal Article
AIDS Research and Human Retroviruses, ISSN 0889-2229, 01/2019, Volume 35, Issue 1, pp. 4 - 48
Interferon-α (IFN-α) plays a vital role in combating viral infections especially in the early control after infection. However, the HIV infection has shown... 
Immunology | HIV-1 | plasmacytoid dendritic cells | AKT | interferon-α | IRF-7
Journal Article
Revue de Medecine Interne, ISSN 0248-8663, 11/2014, Volume 35, Issue 11, pp. 715 - 722
Erdheim-Chester disease is a rare and orphan disease. Despite having been overlooked previously, numerous new cases have been diagnosed more recently. The... 
Interferon-α | BRAF | Erdheim-Chester disease | Histiocytosis
Journal Article
Annals of Oncology, ISSN 0923-7534, 8/2008, Volume 19, Issue 8, pp. 1470 - 1476
Background: In patients with untreated metastatic renal cell carcinoma (mRCC), progression-free survival (PFS) was longer with bevacizumab + interferon (IFN)-α... 
Interferon-α | Antiangiogenic therapy | Renal cell carcinoma | Vascular endothelial growth factor (VEGF) | Bevacizumab
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 07/2003, Volume 10, Issue 4, pp. 298 - 305
Current therapies for chronic hepatitis B (CHB) have a number of limitations, and better treatment options are needed. Peginterferon α‐2a (40 kDa) is superior... 
chronic hepatitis B | interferon α‐2a | viral DNA | hepatitis B virus | hepatitis B e antigen | alanine transaminase | Hepatitis B e antigen | Alanine transaminase | Interferon α-2a | Hepatitis B virus | Chronic hepatitis B | Viral DNA
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 63, pp. 201 - 217
Journal Article
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 07/2008, Volume 7, Issue 7, pp. 1109 - 1115
Interferon (IFN)-λ, also known as IL-28A, IL-28B or IL-29, is a new type III IFN, which like type I IFN-(α/β), activates common elements of the JAK/STAT... 
Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Antiproliferation | STAT | Interferon-α | Interferon-λ | Apoptosis | apoptosis | interferon-λ | antiproliferation
Journal Article
Liver International, ISSN 1478-3223, 12/2004, Volume 24, Issue 6, pp. 568 - 574
: Aim: Comparing the efficacy of peginterferon α‐2b plus ribavirin with interferon α ‐2b plus ribavirin in Saudi patients with chronic hepatitis C virus (HCV)... 
genotype4 | pegylated interferon α | ribavirin | hepatitis C | Hepatitis C | Pegylated interferon α | Ribavirin | Genotype4
Journal Article
Journal Article
Terapevticheskii arkhiv, ISSN 0040-3660, 01/2017, Volume 89, Issue 7, pp. 99 - 104
Journal Article
Biochemical and Biophysical Research Communications, ISSN 0006-291X, 06/2018, Volume 500, Issue 4, pp. 973 - 980
Long noncoding RNA (LncRNA) PVT1 has recently been reported to be involved in the development of hepatocellular carcinoma (HCC) and hsigh expression of... 
Hepatocellular carcinoma | Signal transducer and activator of transcription 1 | Interferon-α | Long noncoding RNA PVT1 | BIOPHYSICS | Interferon-alpha | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER
Journal Article